Prevalence of Hepatitis A Antibodies in Schoolchildren in Catalonia (Spain) after the Introduction of Universal Hepatitis A Immunization

Journal of Medical Virology

Volumn 73, Issue 2, 2004, Pages 172-176

  Domínguez, Àngela ^a,c   Bruguera, Miquel ^b   Plans, Pere ^a   Costa, Josep ^b   Salleras, Lluís ^a  

^a Generalitat of Catalonia ^*  (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

Epidemiology; Hepatitis A virus; Seroprevalence; Vaccine

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; CHILD; DEMOGRAPHY; ENDEMIC DISEASE; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMIGRANT; IMMUNIZATION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SCHOOL; SOCIOECONOMICS; SPAIN; STATISTICAL SIGNIFICANCE; VACCINATION;

ADOLESCENT; CHILD; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HUMANS; MALE; MASS IMMUNIZATION; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SPAIN;

HEPATITIS A VIRUS;

EID: 2142750133     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20072     Document Type: Article

References (29)

1. Altman C, Molinie C, Soudiere S, Denee JM, Buisson Y, Buffet C. 1996. Viral hepatitis A with prolonged course in adults. Gastroenterol Clin Biol 20:42-46.
2. Armstrong GI, Bell BP. 2002. Hepatitis A virus infection in the United States: Model-based estimates and implications for childhood immunization. Pediatrics 109:839-845.
3. Bader TF. 1995. Viral hepatitis: Practical evolution and treatment. Seattle: Hogrefe and Humber Publishers. 248 p.
4. Beran J, Douda P, Rychly R. 1999. Seroprevalence of viral hepatitis A in the Czech Republic. Eur J Epidemiol 15:805-808.
5. Brown EA, Stapleton JT. 2003. Hepatitis A virus. In: Murray PR, Baron EJ, Jorfensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical microbiology, 8th edn. Washington: American Society for Microbiology. pp 1452-1459.
6. Bruguera M, Salleras L, Planas P, Vidal J, Navas E, Dominguez A, Batalla J, Taberner JL, Espuñes J. 1999. Changes in the seroepidemiology of hepatitis A virus infection in Catalonia (Spain) from 1989 to 1996. Implications for a new vaccination strategy. Med Clin (Barc) 112:406-408.
7. Crowcroft NS, Waslh B, Davison KL, Gungabissoon U. 2001. Guidelines for the control of hepatitis A virus infection. Commun Dis Public Health 41:213-227.
8. Das K, Jain A, Gupta S, Kapoor S, Gupta RK, Chakravorty A, Kar P. 2000. The changing epidemiological pattern of hepatitis A in an urban population of India: Emergence of a trend similar to the European countries. Eur J Epidemiol 16:507-510.
9. Diel R, Schneider S. 2001. Transmission of hepatitis A in Hamburg, Germany, 1998-1999-A prospective population based study. Eur J Epidemiol 17:175-182.
10. Domínguez A, Salleras L, Carmona G, Batalla J. 2003. Effectiveness of a program of mass hepatitis A vaccination in preadolescents. Vaccine 21:698-701.
11. Feinstone SM, Gust ID. 2000. Hepatitis A virus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, 5th edn. Philadelphia: Churchill Livingstone. pp 1920-1940.
12. Gandolfo GM, Ferri GM, Conti L, Antenucci A, Marrone R, Frasca AM, Vitelli G. 2003. Prevalence of infections by hepatitis A, B, C, and E viruses in two different socioeconomic groups of children from Santa Cruz, Bolivia. Med Clin (Barc) 120:725-727.
13. Giesecke J. 2002. Modern infectious disease epidemiology, 2nd edn. London: Arnold. 268 p.
14. Joines RW, Blatter M, Abraham Betel A, Xie F, De Clercq N, Blaine Y, Reisinger KS, Kuhnen A, Parenti DL. 2001. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults. Vaccine 19:4710-4719.
15. Kallinowski B, Knoll A, Lindner E, Sanger R, Stremmel W, Vollmar J, Zieger B, Jilg W. 2000. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course? Vaccine 19:16-22.
16. Koff RS. 1995. Seroepidemiology of hepatitis A in the United States. J Infect Dis 171(Suppl 1):S19-S23.
17. Leach CT, Koo FC, Hilsenbeck SG, Jenson HB. 1999. The epidemiology of viral hepatitis in children in South Texas: Increased prevalence of hepatitis A along the Texas-Mexico border. J Infect Dis 180:509-513.
18. Lee A, Cheng F, Lan L, Fabb WE. 2000. Should adolescents be vaccinated against hepatitis A: The Hong Kong experience. Vaccine 18:941-946.
19. Levy I, Chen D, Sherman M, Smith D, Krajden M. 2001. Hepatitis A virus seroprevalence in 1000 university students in Toronto. Can Commun Dis Rep 27:93-96.
20. Office of Population Censuses and Surveys. 1980. Classification of occupations. London: HMSO.
21. Peach D, McMahon BJ, Bulkow L, Funk E, Harpaz R, Margolis HS. 2002. Impact of recurrent epidemics of hepatitis A virus infection on population immunity levels: Bristol Bay, Alaska. J Infect Dis 186:1081-1085.
22. Pérez-Trallero E, Cilla G, Urbieta M, Domonsoro M, Otero F, Marimon JM. 1994. Falling incidence and prevalence of hepatitis A in Northern Spain. Scand J Infect Dis 26:133-136.
23. Rivera F, Ruiz J, Garcia de Pesquera F. 1998. Evolution of the prevalence of hepatitis A antibody in Seville. Aten Primaria 21:97-100.
24. Roy E, Haley N, Leclerc P, Cédras L, Bédard L, Allard R. 2002. Seroprevalence and risk factors for hepatitis A among Montreal street youth. Can J Public Health 93:52-54.
25. Salleras L, Plans P, Vidal J, Dominguez A, Navas E, Urbitzondo L, Espuñes J, Batalla J, Bruguera M. 2000. Serological evaluation of the universal hepatitis B vaccination programme of pre-adolescents in Catalonia (Spain). Vacunas 1:3-6.
26. Shapiro CN, Margolis HS. 1993. Worldwide epidemiology of hepatitis A virus infection. J Hepatol 18(Suppl 2):511-514.
27. Tanaka J. 2000. Hepatitis A shifting epidemiology in Latin America. Vaccine 18(Suppl 1):557-560.
28. Thermorshuizen F, Dorigo-Zetsma JW, de Melker HE, Van den Hof S, Spaendonck C-V. 2000. The prevalence of antibodies to hepatitis A virus and its determinants in the Netherlands: A population-based survey. Epidemiol Infect 124:459-466.
29. Thoelen S, Van Damme P, Leentvaar-Kuypers A, Leroux-Roels G, Bruguera M, Frei PC, Bakasenas V, Safary A. 1999. The first combined vaccine against hepatitis A and B: An overview. Vaccine 17:1657-1662.